These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11449531)

  • 21. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
    Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
    J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
    Malo JL; Cartier A; Ghezzo H; Mark S; Brown J; Laviolette M; Boulet LP
    Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate.
    Niitsuma T; Okita M; Sakurai K; Morita S; Tsuyuguchi M; Matsumura Y; Hayashi T; Koshishi T; Oka K; Homma M
    J Asthma; 2003; 40(5):515-22. PubMed ID: 14529101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
    Ayres JG; Bateman ED; Lundbäck B; Harris TA
    Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults.
    Wilson AM; Lipworth BJ
    Br J Clin Pharmacol; 1999 Oct; 48(4):579-85. PubMed ID: 10583029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of high-dose fluticasone propionate and budesonide on lung function and asthma exacerbations in patients with severe asthma.
    Heinig JH; Boulet LP; Croonenborghs L; Möllers MJ
    Respir Med; 1999 Sep; 93(9):613-20. PubMed ID: 10542974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment.
    Malerba M; Bossoni S; Radaeli A; Mori E; Bonadonna S; Giustina A; Tantucci C
    Chest; 2005 Feb; 127(2):515-21. PubMed ID: 15705990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluticasone propionate in children with moderate asthma.
    Hoekstra MO; Grol MH; Bouman K; Stijnen T; Köeter GH; Kauffman HF; Gerritsen J
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1039-44. PubMed ID: 8887604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma.
    Ferguson AC; Van Bever HP; Teper AM; Lasytsya O; Goldfrad CH; Whitehead PJ
    Respir Med; 2007 Jan; 101(1):118-29. PubMed ID: 16735113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H; Wagner M; Krishnaswami S; Dimova H; Tang Y; Falcoz C; Daley-Yates PT; Krieg M; Stöckmann R; Barth J; Lawlor C; Möllmann AC; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
    Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
    Weiner P; Berar-Yanay N; Davidovich A; Magadle R
    Chest; 1999 Oct; 116(4):931-4. PubMed ID: 10531155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation.
    De Benedictis FM; Del Giudice MM; Vetrella M; Tressanti F; Tronci A; Testi R; Dasic G;
    J Asthma; 2005 Jun; 42(5):331-6. PubMed ID: 16116682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
    Dyer MJ; Halpin DM; Stein K
    BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ
    Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects.
    Grove A; Allam C; McFarlane LC; McPhate G; Jackson CM; Lipworth BJ
    Br J Clin Pharmacol; 1994 Dec; 38(6):527-32. PubMed ID: 7888291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.